PhD Statistics Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Currently enrolled in a PhD Program in Statistics or Biostatistics
  • Passed qualification exam
  • Will complete the third year by May 2026
  • Proficient in statistical programming languages/software such as SAS, R, Python, etc
  • Interpersonal communication skills for effective customer consultation
  • Technical expertise and application with working knowledge of experimental design and statistical analysis
  • Creativity and innovation
  • Demonstrated problem solving ability and strategic thinking

Responsibilities

  • Partner with experts in statistics, basic science and medical to optimize drug discovery and development processes
  • Introduce and apply innovative methodology and tools to solve critical problems
  • Be accurate and creative in communicating results
  • Be up to date on novel and state of the art data and analytics technologies and approaches
  • Challenge yourself and others to be a life-long learner and always look for better ways to deliver

Skills

Key technologies and capabilities for this role

StatisticsBiostatisticsBayesian statisticsMachine LearningCausal InferenceAdaptive DesignsGenetic AnalysisBiomarker Analysis

Questions & Answers

Common questions about this position

What are the basic qualifications for the PhD Statistics Intern position?

Candidates must be currently enrolled in a PhD program in Statistics or Biostatistics, have passed the qualification exam, and will complete the third year by May 2026.

What skills are preferred for this internship?

Preferred skills include proficiency in statistical programming languages such as SAS, R, Python; interpersonal communication skills; technical expertise in experimental design and statistical analysis; creativity and innovation; and demonstrated problem-solving and strategic thinking.

Is this a full-time internship?

Yes, the employment type is full time.

What is the company culture like in the Global Statistical Sciences department?

The department values analytics and data-driven decisions, innovation through state-of-the-art methods, lifelong learning, and putting people first while contributing to patients' lives.

What opportunities are there after the internship?

All interns will be considered for full-time positions based on their internship performance.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI